Ritonavir
- All
- News
- Videos
-
WHO Stops Hydroxychloroquine, HIV Drug Trials Among COVID-19 Patients: Report
The World Health Organisation on Saturday has stopped its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.
-
WHO Testing Interim Data From COVID-19 Trial On HIV Drugs
The World Health Organization is looking at interim data from its large multi-country trial of the combination of HIV drugs Lopinavir and Ritonavir to treat COVID-19 patients, the UN agency's chief scientist Soumya Swaminathan said on Thursday.
-
Health Ministry Suggests Anti-HIV Drug Combination For Coronavirus
The Union Health Ministry has recommended use of anti-HIV drug combinations Lopinavir and Ritonavir on a case-to-case basis depending upon the severity of the condition of a patient having coronavirus infection.
-
Aurobindo Pharma Gets USFDA Nod for Anti-HIV Tablets
The United States Food and Drug Administration (USFDA) has given tentative approval to Aurobindo Pharma's Ritonavir tablets in the strength of 100 mg, FDA said on its website.
-
Cipla Gets US Regulator's Nod for Lopinavir, Ritonavir Oral Pellets
Cipla MD & Global CEO Subhanu Saxena said: "This innovative way of drug delivery through oral pellets for some of society's youngest AIDS sufferers reiterates our commitment to provide access to life saving medicines in the fight against HIV/ AIDS."
-
India rejects US company's patent for anti-HIV drugs
What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies, producing lifesaving drugs, pushing for patents so generic companies cannot produce them at much lower prices. However, in a much needed relief to Indian pharmaceutical companies as well as patients, India rejected a patent application fil...
-
WHO Stops Hydroxychloroquine, HIV Drug Trials Among COVID-19 Patients: Report
The World Health Organisation on Saturday has stopped its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.
-
WHO Testing Interim Data From COVID-19 Trial On HIV Drugs
The World Health Organization is looking at interim data from its large multi-country trial of the combination of HIV drugs Lopinavir and Ritonavir to treat COVID-19 patients, the UN agency's chief scientist Soumya Swaminathan said on Thursday.
-
Health Ministry Suggests Anti-HIV Drug Combination For Coronavirus
The Union Health Ministry has recommended use of anti-HIV drug combinations Lopinavir and Ritonavir on a case-to-case basis depending upon the severity of the condition of a patient having coronavirus infection.
-
Aurobindo Pharma Gets USFDA Nod for Anti-HIV Tablets
The United States Food and Drug Administration (USFDA) has given tentative approval to Aurobindo Pharma's Ritonavir tablets in the strength of 100 mg, FDA said on its website.
-
Cipla Gets US Regulator's Nod for Lopinavir, Ritonavir Oral Pellets
Cipla MD & Global CEO Subhanu Saxena said: "This innovative way of drug delivery through oral pellets for some of society's youngest AIDS sufferers reiterates our commitment to provide access to life saving medicines in the fight against HIV/ AIDS."
-
India rejects US company's patent for anti-HIV drugs
What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies, producing lifesaving drugs, pushing for patents so generic companies cannot produce them at much lower prices. However, in a much needed relief to Indian pharmaceutical companies as well as patients, India rejected a patent application fil...
